Suppr超能文献

低强度脉冲超声影响延迟临床骨折愈合中RUNX2免疫阳性成骨细胞。

Low-intensity pulsed ultrasound affects RUNX2 immunopositive osteogenic cells in delayed clinical fracture healing.

作者信息

Rutten Sjoerd, Nolte Peter A, Korstjens Clara M, Klein-Nulend Jenneke

机构信息

Department of Oral Cell Biology, ACTA-University of Amsterdam and VU University Amsterdam, Research Institute MOVE, Amsterdam, The Netherlands.

出版信息

Bone. 2009 Nov;45(5):862-9. doi: 10.1016/j.bone.2009.07.012. Epub 2009 Jul 23.

Abstract

INTRODUCTION

Osteogenic cell proliferation and differentiation play an important role in adequate fracture healing, and is target for osteoinductive therapies in delayed fracture healing. The aim of this study was to investigate whether low-intensity pulsed ultrasound enhances fracture healing at the tissue level in patients with a delayed union of the osteotomized fibula through an effect on the presence of RUNX2 immunopositive osteogenic cells. The effect was studied in both atrophic and hypertrophic delayed unions.

MATERIALS AND METHODS

Biopsies were obtained from 6 female and 1 male patient (age 43-63) with a delayed union of the osteotomized fibula after a high tibial osteotomy treated for 2-4 months with or without low-intensity pulsed ultrasound in a randomized prospective double-blind placebo-controlled trial. Immunolocalization of RUNX2 protein was performed to identify osteogenic cells. Histomorphometrical analysis was performed to determine the number of cells expressing RUNX2 located within and around the newly formed woven bone at the fracture end (area of new bone formation), and up to 3 mm distant from the fracture end.

RESULTS

Cells expressing RUNX2 were present in all histological sections of control and low-intensity pulsed ultrasound-treated bone evaluated. Within the area of new bone formation, RUNX2 immunopositive cells were found in the undifferentiated soft connective tissue, at the bone surface (presumably osteoblasts), and within the newly formed woven bone. Low-intensity pulsed ultrasound treatment of fibula delayed unions significantly reduced the number of RUNX2 immunopositive cells within the soft connective tissue at the fracture ends, whereas the number of RUNX2 immunopositive cells at the bone surface was not affected. The number of RUNX2 immunopositive cells was similar for the atrophic and hypertrophic delayed unions.

CONCLUSIONS

Immunolocalization of RUNX2 positive cells in delayed unions of the fibula reveals that delayed clinical fracture healing does not result in impairment of osteogenic cell proliferation and/or differentiation at the tissue level, even if delayed unions are clinically regarded as atrophic. Reduced number of osteogenic RUNX2 immunopositive cells within the soft connective tissue, and unchanged number of RUNX2 immunopositive cells at the bone surface, implicate that low-intensity pulsed ultrasound does not increase osteogenic cell presence, but likely affects osteogenic cell differentiation.

摘要

引言

成骨细胞的增殖和分化在骨折的充分愈合中起着重要作用,并且是延迟骨折愈合的骨诱导治疗的靶点。本研究的目的是通过研究RUNX2免疫阳性成骨细胞的存在情况,来调查低强度脉冲超声是否能在组织水平上促进截骨腓骨延迟愈合患者的骨折愈合。对萎缩性和肥大性延迟愈合均进行了该效应的研究。

材料与方法

在一项随机前瞻性双盲安慰剂对照试验中,从6名女性和1名男性患者(年龄43 - 63岁)身上获取活检样本,这些患者在高位胫骨截骨术后出现截骨腓骨延迟愈合,接受了2 - 4个月的低强度脉冲超声治疗(有或无)。进行RUNX2蛋白的免疫定位以识别成骨细胞。进行组织形态计量分析,以确定在骨折端新形成的编织骨内及周围(新骨形成区域)以及距骨折端3毫米范围内表达RUNX2的细胞数量。

结果

在评估的对照骨和低强度脉冲超声治疗骨的所有组织学切片中均存在表达RUNX2的细胞。在新骨形成区域内,在未分化的软结缔组织、骨表面(可能是成骨细胞)以及新形成的编织骨内均发现了RUNX2免疫阳性细胞。低强度脉冲超声治疗腓骨延迟愈合显著减少了骨折端软结缔组织内RUNX2免疫阳性细胞的数量,而骨表面RUNX2免疫阳性细胞的数量未受影响。萎缩性和肥大性延迟愈合中RUNX2免疫阳性细胞的数量相似。

结论

腓骨延迟愈合中RUNX2阳性细胞的免疫定位显示延迟的临床骨折愈合在组织水平上不会导致成骨细胞增殖和/或分化受损,即使延迟愈合在临床上被视为萎缩性。软结缔组织内成骨RUNX2免疫阳性细胞数量减少,而骨表面RUNX2免疫阳性细胞数量不变,这表明低强度脉冲超声不会增加成骨细胞的存在,但可能影响成骨细胞的分化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验